M&A: To Deal or Not to Deal

Authored by Jacob Ambrose Willson, Senior Editor, Criticaleye

In a capital constrained environment, some might argue that now is not the time for businesses to be pursuing growth via M&A. Others might posit that the best deals are struck at weak points in the economic cycle. Senior Editor Jacob Ambrose Willson asks Criticaleye Members for their views on executing M&A in 2023 and beyond.

Featuring Commentary From:

Michel Driessen, Senior Partner, Strategy and Transactions, EY
Alastair Mills, Managing Director & Head of European Business Services, H.I.G. Capital
Michael Teixeira, CEO, MVF
Helen Wiseman, Chair, Elixinol Wellness

Share this with your Community



Contributors
Alastair Mills
Managing Director & Head of European Business Services
H.I.G. European Capital Partners LLP
Helen Wiseman
NED & Audit Committee Chair
Bid Corporation
Michael Teixeira
Chief Executive Officer
Pacera
Michel Driessen
Partner - Markets Leader UKI, Transaction Advisory Services
EY, More London Place


Click here to download this insight

DOWNLOAD INSIGHT



Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.


Click here to download this insight

Women Leaders in an AI Era: Navigating Opportunity and Change

AI has swiftly become a defining force in business life, reshaping how organisations operate, compete and grow. This report by AlixPartners explores how women in senior leadership are responding to business disruption, ...


Click here to download this insight

Unlocking Volume Growth - Retail's Defining Challenge

Growth within retail is proving harder than ever before, with growing geopolitical and economic uncertainty hitting consumer confidence, impacting inflation and disrupting supply chains. This report by AlixPartners ...


Click here to download this insight

IPEM Allocation and Fundraising Trend Report 2027

The private markets industry is entering a new investment cycle, with LPs increasingly focused on diversification, alpha generation and demonstrable value creation, as return expectations come under pressure. This repor...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 198




British Land GlaxoSmithKline plc NATS AlixPartners LACE Partners London Stock Exchange Group E.ON UK Legal & General NatWest Group Mayborn Group Drax Group plc Hitachi Solutions Stream Lightsource bp Rolls-Royce Global Payments